KNSA earnings date and last-quarter result: last quarter beat, P/E 63.71. Updated 2026-07-23.
Kiniksa Pharmaceuticals International (KNSA) Research Hub
Kiniksa Pharmaceuticals International (KNSA) trades on NASDAQ, GB in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-10-26, shares last closed at 72.98 USD (-4.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 63.71, market cap 4.65B. This hub links to the full technical, earnings and options research available for KNSA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NASDAQ, GB |
| Last close | 72.98 USD (-4.89%) |
| 52-week range | 51.7 USD – 84.06 USD |
| Trend regime | Range |
| 14-day RSI | 41.3 (Bearish) |
| Trailing P/E | 63.71 |
| Market cap | 4.65B |
| Dividend yield | 0.00% |
Available research for KNSA
Covered Call on KNSA: how it works, illustrative setup around the real 72.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on KNSA: how it works, illustrative setup around the real 72.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on KNSA: how it works, illustrative setup around the real 72.98 USD price, max profit/loss, breakeven and when to use it. Educational.
KNSA technical analysis: range, last 72.98 USD, RSI 41.3, 52w range 51.7 USD–84.06 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is KNSA in?
Kiniksa Pharmaceuticals International (KNSA) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, GB.
Is KNSA in an uptrend or downtrend?
As of 2026-10-26, KNSA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is KNSA's trailing P/E ratio?
KNSA's trailing P/E is 63.71, with a market cap of 4.65B. See the earnings research page for full valuation detail.